4//SEC Filing
Neervannan Seshadri 4
Accession 0001827584-23-000004
CIK 0001819790other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:56 PM ET
Size
7.8 KB
Accession
0001827584-23-000004
Insider Transaction Report
Form 4
Neervannan Seshadri
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-03-21$12.89/sh−372$4,795→ 55,465 total - Sale
Common Stock
2023-03-22$12.64/sh−379$4,791→ 55,086 total - Sale
Common Stock
2023-03-23$12.15/sh−390$4,739→ 54,696 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827584
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:56 PM ET
- Size
- 7.8 KB